X
Get new exclusive access to healthcare business reports & breaking news
Pharma
The Gates Foundation has a plan to build a 120-person team and spend $100M a year on its ...
AbbVie has granted Pfizer a non-exclusive license to market its Humira (adalimumab) biosimilar in the U.S., which will ...
Bad news for people who want to protect themselves against the painful rash known as shingles. A national ...
Johnson & Johnson’s advanced VR training modules are designed to give doctors access to a convenient and totally ...
The Department of Justice has announced that Actelion Pharmaceuticals, a subsidiary of Johnson and Johnson, has agreed to ...
After losing a court case in Delaware last week, which caused the shares of drug company Akorn Inc. ...
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on MacroGenics’ Phase 1 trial ...
Biotechnology is an exciting field that uses biological systems to make technological advances. Companies around the world are ...
Christopher Weber, Takeda Pharmaceuticals’ CEO had a wonderful day today. His long political battle to convince company stakeholders ...
